Thermo Fisher Scientific to resell Prosolia’s PaperSpray® technology as factory option to its mass spectrometers

Labs performing clinical research and forensic toxicology of dried sample spots can now purchase Thermo Scientific mass spectrometry (MS) systems equipped from the factory with PaperSpray technology, designed to virtually eliminate sample preparation for screening and quantitation of drugs in biological fluid samples.

Thermo Fisher Scientific has entered into a value added reseller agreement with Prosolia, Inc. to permit Thermo Fisher to sell the Prosolia Velox 360™ device with Thermo Scientific MS systems, providing a single point of contact for purchasing, installation and service.

The Velox 360 device is an automated sample handling and ionization source for mass spectrometry featuring PaperSpray technology. PaperSpray technology combines paper substrates with electrospray ionization, designed to simplify sample preparation and speed up mass spectrometry analysis of biological fluids.

The Velox 360 device can be coupled to The Thermo Scientific Q Exactive Series MS family as well as the company’s triple quadrupole and ion trap instruments.

Please visit www.prosolia.com for more information about the Velox 360 device.

Please visit www.planetorbitrap.com for more information about the Q Exactive Series.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is the world leader in serving science, with revenues of $17 billion and approximately 50,000 employees in 50 countries. Our mission is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics and increase laboratory productivity. Through our premier brands – Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services – we offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive support. For more information, please visit www.thermofisher.com.

PaperSpray” is a registered trademark of Purdue Research Foundation.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Thermo Fisher Scientific Inc.. (2015, March 30). Thermo Fisher Scientific to resell Prosolia’s PaperSpray® technology as factory option to its mass spectrometers. News-Medical. Retrieved on August 05, 2021 from https://www.news-medical.net/news/20150330/Thermo-Fisher-Scientific-to-resell-Prosolias-PaperSpray-technology-as-factory-option-to-its-mass-spectrometers.aspx.

  • MLA

    Thermo Fisher Scientific Inc.. "Thermo Fisher Scientific to resell Prosolia’s PaperSpray® technology as factory option to its mass spectrometers". News-Medical. 05 August 2021. <https://www.news-medical.net/news/20150330/Thermo-Fisher-Scientific-to-resell-Prosolias-PaperSpray-technology-as-factory-option-to-its-mass-spectrometers.aspx>.

  • Chicago

    Thermo Fisher Scientific Inc.. "Thermo Fisher Scientific to resell Prosolia’s PaperSpray® technology as factory option to its mass spectrometers". News-Medical. https://www.news-medical.net/news/20150330/Thermo-Fisher-Scientific-to-resell-Prosolias-PaperSpray-technology-as-factory-option-to-its-mass-spectrometers.aspx. (accessed August 05, 2021).

  • Harvard

    Thermo Fisher Scientific Inc.. 2015. Thermo Fisher Scientific to resell Prosolia’s PaperSpray® technology as factory option to its mass spectrometers. News-Medical, viewed 05 August 2021, https://www.news-medical.net/news/20150330/Thermo-Fisher-Scientific-to-resell-Prosolias-PaperSpray-technology-as-factory-option-to-its-mass-spectrometers.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
You might also like... ×
Thermo Fisher Scientific collaborates with AstraZeneca and University of Nebraska Medical Center